Back to Gastroenterology
Gastroenterologyv1.0Evidence-Based

Milan Criteria for Liver Transplantation

Assesses suitability of patients for liver transplant with cirrhosis and hepatocellular carcinoma (HCC), recommended by AASLD guidelines

Clinical Input Parameters

cm
Range: 0 — 20 cm
cm
Range: 0 — 20 cm
Clinical Assessment
Awaiting Parameters
milan criteria met
—Points
Ready to Calculate

Awaiting Clinical Input

Enter the clinical input parameters on the left and click Run Clinical Assessment to evaluate this medical calculator with deterministic clinical scoring.

Open in Web App
Clinical decision support tool for licensed medical practitioners. Confirm independently before prescribing or clinical action.

When & Why to Use

The Milan Criteria for Liver Transplantation is utilized in clinical practice for risk stratification, diagnostic probability estimation, and treatment decision-making within gastroenterology.

Use this tool during initial patient intake, emergency department workup, or bedside assessment when objective clinical scoring is required to guide management or admission decisions.

Clinical Formula & Scoring Logic

Milan Criteria: (1 tumor ≤5 cm) OR (2-3 tumors, each ≤3 cm) AND no extrahepatic disease AND no major vessel involvement

Clinical Pearls & Practice Notes

  • Imaging should be high-quality multiphasic CT or MRI
  • Count all viable tumors (exclude completely necrotic lesions after treatment)
  • Patients with AFP >1000 ng/mL must be downstaged to AFP <500 ng/mL to be eligible
  • Downstaging to Milan criteria requires maintenance for 3-6 months before transplant eligibility
  • MELD exception points: MMaT-3 (median MELD at transplant minus 3) after 6-month waiting period
  • Consider bridging therapy while on waitlist to prevent tumor progression

Evidence & Literature Citations

  1. Mazzaferro V, Regalia E, Doci R, Andreola S, Pulvirenti A, Bozzetti F, et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med. 1996 Mar 14;334(11):693-9. doi: 10.1056/NEJM199603143341104.
  2. Mazzaferro V, Llovet JM, Miceli R, Bhoori S, Schiavo M, Mariani L, et al. Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective, exploratory analysis. Lancet Oncol. 2009 Jan;10(1):35-43. doi: 10.1016/S1470-2045(08)70284-5.
  3. Mazzaferro V, Bhoori S, Sposito C, Bongini M, Langer M, Miceli R, et al. Milan criteria in liver transplantation for hepatocellular carcinoma: an evidence-based analysis of 15 years of experience. Liver Transpl. 2011 Oct;17 Suppl 2:S44-57. doi: 10.1002/lt.22365.
  4. Marrero JA, Kulik LM, Sirlin CB, Zhu AX, Finn RS, Abecassis MM, et al. Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases. Hepatology. 2018 Aug;68(2):723-750. doi: 10.1002/hep.29913.

Score Interpretation Ranges

Meets Criteria0 – 0 pts

Eligible for liver transplantation

Does Not Meet Criteria1 – 1 pts

Not eligible for liver transplantation

Need Clinical Suite Access?

Run this calculator with patient history, laboratory integration, and drug interaction safety checks on the DexaMed clinician app.

Open in Web App

Clinical Decision Support (CDS) Notice & Legal Disclaimer

This medical calculator and its scoring interpretation are provided strictly for licensed healthcare professionals and medical trainees as an educational and clinical decision support instrument. It does not replace independent clinical judgment, comprehensive patient history, physical examination, or attending physician oversight. Not FDA-cleared as an autonomous diagnostic medical device. Read the full DexaMed Medical Disclaimer.